To compare the clinical effect of tegoprazan and esomeprazole in the treatment of reflux esophagitis(RE).
A total of 160 patients with RE admitted to our hospital from August 2023 to January 2025 were selected as research subjects and randomly divided into the study group and the control group, with 80 cases in each group. The study group was treated with tegoprazan, while the control group was treated with esomeprazole. Both groups received continuous treatment for 8 weeks. After treatment, the clinical efficacy of the two groups was evaluated.The scores of Reflux Disease Questionnaire(RDQ) and Gastroesophageal Reflux Disease Questionnaire(GERDQ), the changes in the levels of gastrointestinal hormones, inflammatory factors and oxidative stress indicators before and after treatment were compared between the two groups.
The total effective rate of the study group was higher than that of the control group(93.75% vs. 82.50%, P<0.05). After treatment, the RDQ and GERDQ scores of both groups decreased compared with those before treatment, and the scores of the study group were lower than those of the control group(all P<0.05). The levels of gastrin, motilin and superoxide dismutase in both groups increased compared with those before treatment, and the levels in the study group were higher than those in the control group(P<0.05). The levels of vasoactive intestinal peptide, cholecystokinin, high-sensitivity C-reactive protein, interleukin-6, malondialdehyde and inducible nitric oxide synthase in both groups decreased compared with those before treatment, and the levels in the study group were lower than those in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).
Compared with esomeprazole, tegoprazan can effectively improve the therapeutic effect in RE patients. It has additional effects in regulating gastrointestinal hormone levels, relieving inflammatory response and oxidative stress response, and the safety profiles of the two drugs are comparable.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |